Table 4. Factors associated with a poor outcome in VL (at 6 months after VL diagnosis) in the univariate analysis.
Variables | VL Clinical outcome of VL (%) | p value | |
Cure | Poor outcome | ||
HIV infection | 18/57 (32) | 27/31 (87) | 0.00 |
Drug abuse § | 8/57 (14) | 13/31 (42) | 0.00 |
Alcohol abuse | 23/57 (40) | 22/31 (71) | 0.01 |
Comorbidity | 12/57 (21) | 13/31 (42) | 0.09 |
Malnutrition | 20/57 (35) | 17/31 (58) | 0.12 |
Bleeding | 9/57 (16) | 10/31 (32) | 0.10 |
Hypotension | 5/57 (9) | 7/31 (23) | 0.10 |
Previous VL episode | 15/31 (71) | 6/21 (28) | 0.00 |
Median percentage of neutrophils (IR) | 48 (42–56) | 59 (49–68) | 0.00 |
Median platelet count (IR), cells/L | 9.9(6.8–12.6×104) | 10.1(5.5–16.6×104) | 0.19 |
VL: visceral leishmaniasis IR: 25–75% interquartile range.
in all cases, refers to the use of inhaled drugs derived from cocaine.